Belgian biopharmaceutical company Cardio3 Biosciences, which is backed by a consortium of venture capital firms, has announced that it is considering listing new shares in an IPO.
GP installs former Atos CEO as chairman; deal is partial exit for Apax Partners' India-based Healthium
Fund’s recent focus has been senior secured deals for companies seeking financing amid a tough credit market
Direct private equity co-heads Thomas Vatier and Jay Takefman on the firm’s family roots and its approach to the current market
Triton will exit German web hosting provider after growing revenues to EUR 120m from EUR 2m